Infectious Diseases: Confronting the Triple Threat - Humans, Animals, and the Environment
A Special Hill Briefing was held on July 10, 2008 in the Dirksen Senate Office Building. The briefing speakers included: Lonnie J. King, DVM, Director of the National Center for Zoonotic, Vector-Borne, and Enteric Diseases (ZVED) Centers for Disease Control and Prevention Marguerite Pappaioanou, DVM, MPVM, Ph.D., Dip ACVPM, Association of American Veterinary Medical Colleges and Ronald M. Atlas, Ph.D., American Society for Microbiology. The briefing presentations are posted on the web.
May 20, 2010 – ASM Submits Comments on CDC’s revised draft guideline, Prevention of Perinatal Group B Strep Infection
On May 20, the Committees on Laboratory Practices and Professional Affairs provided comments to the Centers for Disease Control and Prevention (CDC) regarding its revised draft guideline, Prevention of Perinatal Group B Strep Infection. The comments focused on the laboratory portion of the guideline.
Food and Drug Administration Science Board Report
February 1, 2008 - ASM Comments on the FDA Science Board Report
The ASM sent comments to the FDA regarding the Science Board Report to evaluate FDA's science based capacities to meet current and future public health challenges.
CDC Health Protection Research Guide
January 13, 2006 - PSAB Submits Comments on CDC draft Health Protection Research Guide
On January 13, the the Public and Scientific Affairs Board (PSAB) submitted comments to the Centers for Disease Control and Prevention regarding its draft Health Protection Research Guide, which was announced in the Federal Register on November 18, 2005.
September 13, 2005 - Strengthening Microbiologic Laboratory Systems to Support Infectious Disease Prevention and Control Programs in Under-Resourced Countries, Final Meeting Report
On May 9-10, 2005, the Public and Scientific Affairs Board (PSAB) sponsored a meeting to discuss laboratories in under-resourced countries. The meeting focused on 1) the need to increase the awareness of the importance of laboratories to the success of public health programs in under-resourced countries and 2) ways to build on existing or planned programs that require a good laboratory system for a program’s success.
October 12, 2004 - ASM Submits Comments to CDC on Vaccine Safety
The ASM submitted comments to the Centers for Disease Control and Prevention (CDC) in response to a request for comments that was published in the Morbidity and Mortality Weekly Report (MMWR) regarding the current state of CDC’s Vaccine Safety Program.
October 26, 2004 - ASM Comments on the Department of Health and Human Services Pandemic Influenza Plan
The ASM sent comments to the National Vaccine Program Office (NVPO), Department of Health and Human Services (DHHS) on the Draft Pandemic Influenza Preparedness and Response Plan, which was announced in the Federal Register on August 27, 2004.